The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant-Reference-Cited by-同舟云学术

The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant

Published:2019-01-28 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lauté-Caly Delphine L.^ORCID,Raftis Emma J.,Cowie Philip,Hennessy Emma,Holt Amy,Panzica D. Alessio,Sparre Christina,Minter Beverley,Stroobach Eline,Mulder Imke E.

Funder

4D Pharma plc

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-36926-8.pdf

Reference62 articles.

1. Švec, P. & Franz, C. M. A. P. In The genus Enterococcus in Lactic Acid Bacteria: Biodiversity and Taxonomy 175–211 (John Wiley & Sons, Ltd, 2014).

2. Zhong, Z. et al. Comparative genomic analysis of the genus Enterococcus. Microbiol Res 196, 95–105, https://doi.org/10.1016/J.MICRES.2016.12.009 (2017).

3. Williams, A. M., Rodrigues, U. M. & Collins, M. D. Intrageneric relationships of enterococci as determined by reverse transcriptase sequencing of small-subunit rRNA. Res Microbiol, 67–74, https://doi.org/10.1016/0923-2508(91)90098-U (1991).

4. Palmer, K. L. et al. Comparative genomics of enterococci: variation in Enterococcus faecalis, clade structure in E. faecium, and defining characteristics of E. gallinarum and E. casseliflavus. MBio 3, e00318–00311, https://doi.org/10.1128/mBio.00318-11 (2012).

5. Vos, P. et al. In Enterococci in Bergey’s manual of systematic bacteriology, Volume 3: The Firmicutes 594–606 (Springer, 2011).

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease;Journal of Autoimmunity;2024-09

2. The gut microbiome and dietary metabolites in the treatment of renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-08

3. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches;Medical Oncology;2024-06-14

4. Advancements in synthetic biology-based bacterial cancer therapy: A modular design approach;Critical Reviews in Oncology/Hematology;2023-10

5. Tumor Immune Microenvironment in Gynecologic Cancers;Cancers;2023-07-28